Results 1 to 10 of about 261,869 (302)

Vaccines for Influenza [PDF]

open access: yesVaccines, 2021
Two reviews by Harding and Heaton [...]
Apostolos P. Georgopoulos   +4 more
openaire   +3 more sources

Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. [PDF]

open access: yes, 2013
BackgroundLittle is known on the effectiveness of influenza vaccine in ESRD patients. This study compared the incidence of hospitalization, morbidity, and mortality in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) between cohorts ...
Chang, Chiz-Tzung   +9 more
core   +9 more sources

Influenza Virus and Vaccination [PDF]

open access: yesPathogens, 2020
Influenza virus infections represent a serious public health problem causing contagious respiratory disease and substantial morbidity and mortality in humans, resulting in a considerable economic burden worldwide. Notably, the number of deaths due to influenza exceeds that of any other known pathogen.
Aitor Nogales, Marta L. DeDiego
openaire   +6 more sources

Influenza and the influenza vaccine [PDF]

open access: yesCanadian Medical Association Journal, 2007
Influenza, or the “flu,” is an infection caused by the influenza virus. The virus infects the nose and throat, and it can sometimes spread to the lungs. Influenza commonly causes acute fever, cough, chills, tiredness, body aches and, in young children, ear aches.
Joanne M. Langley   +2 more
openaire   +3 more sources

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease [PDF]

open access: yes, 2016
Current influenza vaccines are effective but imperfect, failing to cover against emerging strains of virus and requiring seasonal administration to protect against new strains. A key step to improving influenza vaccines is to improve our understanding of
Bogen, B   +8 more
core   +5 more sources

Influenza vaccines [PDF]

open access: yesVaccine, 2009
Influenza A viruses pose a substantial threat to the human population whether by purposeful manipulation and release or by the natural process of interspecies transmissions from animal reservoirs. The challenge with preparing for these events with vaccination strategies is that the best forms of protective immunity target the most variable of the viral
A H, Ellebedy, R J, Webby
openaire   +2 more sources

Influenza and Influenza Vaccine: A Review [PDF]

open access: yesJournal of Midwifery & Women's Health, 2021
AbstractInfluenza is a highly contagious, deadly virus, killing nearly half a million people yearly worldwide. The classic symptoms of influenza are fever, fatigue, cough, and body aches. In the outpatient setting, diagnosis can be made by clinical presentation with optional confirmatory diagnostic testing.
Cynthia Nypaver   +2 more
openaire   +3 more sources

Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection [PDF]

open access: yes, 2017
The emergence of multiple novel lineages of H1 and H3 influenza A viruses in swine has confounded control by inactivated vaccines. Because of substantial genetic and geographic heterogeneity among circulating swine influenza viruses, one vaccine strain ...
Claes, Gerwin   +8 more
core   +2 more sources

Influenza vaccination

open access: yesNursing Older People, 1999
Nurses have an important part to play in dispelling myths about influenza vaccination and in actively encouraging older people to attend for vaccination. Irene Schofield discusses the issues.
A, Uma, P, Thirumalaikolundusubramanian
openaire   +5 more sources

Influenza vaccination uptake among people aged over 85 years: an audit of primary care practice in the UK [PDF]

open access: yes, 2014
Public health research and national guidelines have advocated for seasonal influenza vaccination in the elderly. General practice has established itself as an ideal setting for the safe administration and monitoring of vaccines.1 Due to waning immune
Arnott, ND, Fitchett, JR
core   +2 more sources

Home - About - Disclaimer - Privacy